CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 54.58 CNY -0.47% Market Closed
Market Cap: 8.9B CNY

Wall Street
Price Targets

Price Targets Summary
CanSino Biologics Inc

Wall Street analysts forecast CanSino Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 76.7 CNY with a low forecast of 72.44 CNY and a high forecast of 82.61 CNY.

Lowest
Price Target
72.44 CNY
33% Upside
Average
Price Target
76.7 CNY
41% Upside
Highest
Price Target
82.61 CNY
51% Upside
CanSino Biologics Inc Competitors:
Price Targets
WVE
WAVE Life Sciences Ltd
244% Upside
4151
Kyowa Kirin Co Ltd
26% Upside
570
China Traditional Chinese Medicine Holdings Co Ltd
15% Downside
2096
Simcere Pharmaceutical Group Ltd
16% Upside
EYPT
EyePoint Pharmaceuticals Inc
428% Upside
ORNBV
Orion Oyj
3% Upside
TERN
Terns Pharmaceuticals Inc
596% Upside
JNJ
Johnson & Johnson
13% Upside

Revenue
Forecast

Revenue Estimate
CanSino Biologics Inc

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 3 years is 36%.

N/A
Past Growth
36%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CanSino Biologics Inc's stock price target?
Price Target
76.7 CNY

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 76.7 CNY with a low forecast of 72.44 CNY and a high forecast of 82.61 CNY.

What is CanSino Biologics Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 3 years is 36%.

Back to Top